Home and ambulatory infusion are entering a period of significant regulatory change as federal and state policies reshape where care is delivered, how providers are reimbursed, and which operating models are positioned to create value.
In this perspective, we examine the legislative and regulatory developments shaping the sector, from Medicare home infusion coverage and site-neutral payment reform to state licensure, white bagging, 340B, and PBM dynamics. We also explore how these changes could influence market growth over the next decade and what investors and operators should consider as they evaluate opportunities across the infusion landscape.
Please complete the form to receive this white paper. Upon submission, the white paper will be sent to your inbox.
Perspective Papers 
Insights 
Webinars 